4/A//SEC Filing
Gill Jagi 4/A
Accession 0001213900-21-020789
CIK 0001823857other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:22 PM ET
Size
5.8 KB
Accession
0001213900-21-020789
Insider Transaction Report
Form 4/AAmended
Gill Jagi
DirectorCEO and President10% Owner
Transactions
- Other
Common Stock, par value $0.0001 per share
2020-12-30+0→ 4,950,250 total(indirect: By LLC)
Footnotes (2)
- [F1]The Form 4 for which this Form 4/A is being filed, incorrectly reflected the forfeiture of 656,250 shares after the consummation of the initial public offering. Forfeiture of up to 656,250 shares held by the Reporting Person was only to occur to the extent the underwriter's over-allotment option was not exercised in full. On December 30, 2020, the underwriter's over-allotment was exercised in full. As a result, no shares should have been forfeited. This Form 4/A reflects that the Reporting Person still beneficially owns 4,950,250 shares.
- [F2]Mr. Gill is a member of Viveon Health LLC and has a pecuniary interest in the shares. Mr. Papadopoulos is the managing member of Viveon Health LLC and is deemed to have sole voting and dispositive power over the shares. The business address for Viveon Health LLC is c/o Gibson, Deal & Fletcher, PC, Spalding Exchange, 3953 Holcomb Bridge Road, Suite 200, Norcross Georgia 30092.
Documents
Issuer
Viveon Health Acquisition Corp.
CIK 0001823857
Entity typeother
Related Parties
1- filerCIK 0001838002
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:22 PM ET
- Size
- 5.8 KB